BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 10025594)

  • 1. Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations.
    Sabbadini MG; Manfredi AA; Bozzolo E; Ferrario L; Rugarli C; Scorza R; Origgi L; Vanoli M; Gambini O; Vanzulli L; Croce D; Campana A; Messa C; Fazio F; Tincani A; Anzola G; Cattaneo R; Padovani A; Gasparotti R; Gerli R; Quartesan R; Piccirilli M; Farsi A; Emmi E; Passaleva A
    Lupus; 1999; 8(1):11-9. PubMed ID: 10025594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single photon emission computed tomography and magnetic resonance imaging evaluation in SLE patients with and without neuropsychiatric involvement.
    Castellino G; Padovan M; Bortoluzzi A; Borrelli M; Feggi L; Caniatti ML; Trotta F; Govoni M
    Rheumatology (Oxford); 2008 Mar; 47(3):319-23. PubMed ID: 18218648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychiatric systemic lupus erythematosus: correlation of brain MR imaging, CT, and SPECT.
    Abreu MR; Jakosky A; Folgerini M; Brenol JC; Xavier RM; Kapczinsky F
    Clin Imaging; 2005; 29(3):215-21. PubMed ID: 15855069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic lupus erythematosus patients with past neuropsychiatric involvement are associated with worse cognitive impairment: a longitudinal study.
    Gao Y; Lau EY; Wan JH; Lau CS; Mok MY
    Lupus; 2016 May; 25(6):637-44. PubMed ID: 26700182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral hypoperfusion detected by SPECT in patients with systemic lupus erythematosus is related to clinical activity and cumulative tissue damage.
    López-Longo FJ; Carol N; Almoguera MI; Olazarán J; Alonso-Farto JC; Ortega A; Monteagudo I; González CM; Carreño L
    Lupus; 2003; 12(11):813-9. PubMed ID: 14667096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of single photon emission computerized tomography in neuropsychiatric SLE: a pilot study.
    Kovacs JA; Urowitz MB; Gladman DD; Zeman R
    J Rheumatol; 1995 Jul; 22(7):1247-53. PubMed ID: 7562753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
    Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST
    Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features of central nervous system infections and experience in differential diagnosis from neuropsychiatric lupus erythematosus in a cohort of 8491 patients with systemic lupus erythematosus.
    Jiang M; Shi X; Gao X; Niu J; Hu X; Zhao L; Zhang X
    Arthritis Res Ther; 2019 Aug; 21(1):189. PubMed ID: 31426834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of central nervous system damage in patients with neuropsychiatric systemic lupus erythematosus, demonstrated by magnetization transfer imaging.
    Bosma GP; Rood MJ; Zwinderman AH; Huizinga TW; van Buchem MA
    Arthritis Rheum; 2000 Jan; 43(1):48-54. PubMed ID: 10643699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive and neurologic status in patients with systemic lupus erythematosus without major neuropsychiatric syndromes.
    Kozora E; Arciniegas DB; Filley CM; West SG; Brown M; Miller D; Grimm A; Devore MD; Wingrove C; Zhang L
    Arthritis Rheum; 2008 Nov; 59(11):1639-46. PubMed ID: 18975359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral blood flow abnormalities in neuropsychiatric systemic lupus erythematosus.
    Jia J; Xie J; Li H; Wei H; Li X; Hu J; Meng D; Zhang Y; Zhang X
    Lupus; 2019 Aug; 28(9):1128-1133. PubMed ID: 31315530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial Working Memory Impairment in Patients with Non-neuropsychiatric Systemic Lupus Erythematosus: A Blood-oxygen-level Dependent Functional Magnetic Resonance Imaging Study.
    Zhu CM; Ma Y; Xie L; Huang JZ; Sun ZB; Duan SX; Lin ZR; Yin JJ; Le HB; Sun DM; Xu WC; Ma SH
    J Rheumatol; 2017 Feb; 44(2):201-208. PubMed ID: 28089970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-photon-emission computed tomography analysis of cerebral blood flow in the evaluation of central nervous system involvement in patients with systemic lupus erythematosus.
    Rubbert A; Marienhagen J; Pirner K; Manger B; Grebmeier J; Engelhardt A; Wolf F; Kalden JR
    Arthritis Rheum; 1993 Sep; 36(9):1253-62. PubMed ID: 8216419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluid Attenuated Inversion Recovery (FLAIR) imaging in neuropsychiatric systemic lupus erythematosus.
    Sibbitt WL; Schmidt PJ; Hart BL; Brooks WM
    J Rheumatol; 2003 Sep; 30(9):1983-9. PubMed ID: 12966602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship Between Clinical and Immunological Features with Magnetic Resonance Imaging Abnormalities in Female Patients with Neuropsychiatric Systemic Lupus Erythematosus.
    Wang HP; Wang CY; Pan ZL; Zhao JY; Zhao B
    Chin Med J (Engl); 2016 Mar; 129(5):542-8. PubMed ID: 26904988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium-99m-HMPAO brain SPECT in systemic lupus erythematosus with CNS involvement.
    Lin WY; Wang SJ; Yen TC; Lan JL
    J Nucl Med; 1997 Jul; 38(7):1112-5. PubMed ID: 9225800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations.
    Monastero R; Bettini P; Del Zotto E; Cottini E; Tincani A; Balestrieri G; Cattaneo R; Camarda R; Vignolo LA; Padovani A
    J Neurol Sci; 2001 Feb; 184(1):33-9. PubMed ID: 11231030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychiatric manifestations and antiphospholipid antibodies in pediatric onset lupus: 14 years of experience from a tertiary center of North India.
    Singh S; Gupta MK; Ahluwalia J; Singh P; Malhi P
    Rheumatol Int; 2009 Oct; 29(12):1455-61. PubMed ID: 19306097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus.
    Fragoso-Loyo H; Atisha-Fregoso Y; Nuñez-Alvarez CA; Llorente L
    Lupus; 2016 Apr; 25(4):364-9. PubMed ID: 26466614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuropsychiatric symptoms and findings in systemic lupus erythematosus ].
    Lund C; Gjerstad L
    Tidsskr Nor Laegeforen; 1997 May; 117(14):2043-5. PubMed ID: 9235685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.